- Home
- MNKD vs IAUX Comparison
MNKD vs IAUX Comparison
Compare MNKD & IAUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNKD | IAUX |
|---|---|---|
| Founded | 1991 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2004 | 2021 |
Fundamental Metrics
Financial Performance| Metric | MNKD | IAUX |
|---|---|---|
| Price | $3.85 | $1.28 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | ★ $8.69 | $1.50 |
| AVG Volume (30 Days) | 4.7M | ★ 9.3M |
| Earning Date | 05-06-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 11.76 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $348,966,000.00 | $95,193,000.00 |
| Revenue This Year | $35.81 | $132.25 |
| Revenue Next Year | $11.89 | $89.76 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 22.23 | ★ 89.12 |
| 52 Week Low | $2.23 | $0.55 |
| 52 Week High | $6.51 | $2.24 |
Technical Indicators
Market Signals| Indicator | MNKD | IAUX |
|---|---|---|
| Relative Strength Index (RSI) | 47.65 | 39.21 |
| Support Level | $3.81 | $1.23 |
| Resistance Level | $3.94 | $1.43 |
| Average True Range (ATR) | 0.21 | 0.07 |
| MACD | -0.04 | -0.00 |
| Stochastic Oscillator | 34.25 | 14.63 |
Price Performance
Historical ComparisonAbout MNKD MannKind Corporation
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
About IAUX i-80 Gold Corp.
i-80 Gold Corp is a well-financed gold and silver producer engaged in the exploration, development, and production of gold, silver, and poly-metallic deposits. The Company's principal assets include the Ruby Hill Mine, Lone Tree Mine, Granite Creek Mine, and McCoy-Cove Project.